Cushing's Hub

A resource for healthcare professionals caring for patients with Cushing’s syndrome

This editorial looks at highly important yet non-routine aspects of Cushing’s syndrome and encourages readers to consider aspects of the disease where literature is scarce. Topics include once-in-a-lifetime events necessitating hospitalization – sometimes before diagnosis is made – and practical advice on the use of steroidogenesis inhibitors. The editorial also highlights recent research on the effect of Cushing’s syndrome on pregnancy outcomes.
Latest from across Cushing's Hub
News
|
September 2, 2021

The selective glucocorticoid receptor modulator relacorilant may warrant further investigation for the treatment of endogenous Cushing’s syndrome, suggest phase 2 trial results published in Frontiers in Endocrinology in July 2021.

News
|
August 3, 2021

The 37th Congress of the Société Française d’Endocrinologie – the French Society of Endocrinology – will be held in Le Havre in October 2021.

Case Study
|
July 21, 2021

The second interactive case study explores the management of relapsing Cushing’s disease in a woman of childbearing age with emphasis given to pregnancy planning.

From the Editorial Board: Welcome to Cushing’s Hub

“A website on Cushing’s syndrome? Why would I be interested in a website like that?”
The Editorial Board Members describe the importance of a website dedicated to Cushing’s syndrome and the reasons they signed up for the project.